BACKGROUND: Cancer is now the leading cause of death in persons with HIV. In this study, we gathered current epidemiological data on Aids-defining (AD) and non-Aids-defining (NAD) malignancies among HIV-positive patients in Germany. METHODS: From 2000 to 2007, all 35 specialized HIV outpatient clinics and 189 HIV ambulatory care centers in Germany were contacted and asked to fill out a structured questionnaire on the incidence of malignancies in HIV-positive patients during multiple periods of observation. RESULTS: 552 evaluable data sets were reported. 253 (45.8%) of the reported malignancies were AD. Among the 299 cases (54.2%) of NAD malignancies, there were 214 solid tumors, including 71 anal carcinomas (23.7% of all NAD malignancies), and 85 hematopoietic malignancies, including 29 cases of Hodgkin`s lymphoma (9.7% of all NAD malignancies). The high percentage of NAD malignancy remained constant throughout the entire period of the study. Only a single case of primary cerebral lymphoma was reported after 2001. The number of patients with Hodgkin`s lymphoma rose steadily from 2000 to 2007. CONCLUSION: The spectrum of HIV-associated malignancies has changed since the early days of the HIV epidemic. In Germany, NAD malignancies have become more common than AD malignancies. In particular, anal carcinoma and Hodgkin's lymphoma are much more common among persons with HIV than in the general population. Persons with HIV need more intensive preventive care for cancer than non-infected persons do.
BACKGROUND:Cancer is now the leading cause of death in persons with HIV. In this study, we gathered current epidemiological data on Aids-defining (AD) and non-Aids-defining (NAD) malignancies among HIV-positivepatients in Germany. METHODS: From 2000 to 2007, all 35 specialized HIVoutpatient clinics and 189 HIV ambulatory care centers in Germany were contacted and asked to fill out a structured questionnaire on the incidence of malignancies in HIV-positivepatients during multiple periods of observation. RESULTS: 552 evaluable data sets were reported. 253 (45.8%) of the reported malignancies were AD. Among the 299 cases (54.2%) of NAD malignancies, there were 214 solid tumors, including 71 anal carcinomas (23.7% of all NAD malignancies), and 85 hematopoietic malignancies, including 29 cases of Hodgkin`s lymphoma (9.7% of all NAD malignancies). The high percentage of NAD malignancy remained constant throughout the entire period of the study. Only a single case of primary cerebral lymphoma was reported after 2001. The number of patients with Hodgkin`s lymphoma rose steadily from 2000 to 2007. CONCLUSION: The spectrum of HIV-associated malignancies has changed since the early days of the HIV epidemic. In Germany, NAD malignancies have become more common than AD malignancies. In particular, anal carcinoma and Hodgkin's lymphoma are much more common among persons with HIV than in the general population. Persons with HIV need more intensive preventive care for cancer than non-infected persons do.
Authors: J M Palefsky; H Minkoff; L A Kalish; A Levine; H S Sacks; P Garcia; M Young; S Melnick; P Miotti; R Burk Journal: J Natl Cancer Inst Date: 1999-02-03 Impact factor: 13.506
Authors: Michael J Silverberg; Jacqueline Neuhaus; Mark Bower; Daniela Gey; Angelos Hatzakis; Keith Henry; Jose Hidalgo; Leonardo Lourtau; James D Neaton; Giuseppe Tambussi; Donald I Abrams Journal: AIDS Date: 2007-09-12 Impact factor: 4.177
Authors: Christian Hoffmann; Eva Wolf; Christoph Wyen; Gerd Fätkenheuer; Jan Van Lunzen; Hans-Juergen Stellbrink; Albrecht Stoehr; Andreas Plettenberg; Hans Jaeger; Richard Noppeney; Marcus Hentrich; Nicola Goekbuget; Dieter Hoelzer; Heinz-August Horst Journal: Leuk Lymphoma Date: 2006-09
Authors: M Hentrich; L Maretta; K U Chow; J R Bogner; D Schürmann; P Neuhoff; H Jäger; D Reichelt; M Vogel; M Ruhnke; M Oette; R Weiss; J Rockstroh; K Arasteh; P Mitrou Journal: Ann Oncol Date: 2006-03-24 Impact factor: 32.976
Authors: Tae-Won Kang; Tetyana Yevsa; Norman Woller; Lisa Hoenicke; Torsten Wuestefeld; Daniel Dauch; Anja Hohmeyer; Marcus Gereke; Ramona Rudalska; Anna Potapova; Marcus Iken; Mihael Vucur; Siegfried Weiss; Mathias Heikenwalder; Sadaf Khan; Jesus Gil; Dunja Bruder; Michael Manns; Peter Schirmacher; Frank Tacke; Michael Ott; Tom Luedde; Thomas Longerich; Stefan Kubicka; Lars Zender Journal: Nature Date: 2011-11-09 Impact factor: 49.962
Authors: K Ehren; C Hertenstein; T Kümmerle; J J Vehreschild; J Fischer; D Gillor; C Wyen; C Lehmann; O A Cornely; N Jung; S Gravemann; M Platten; J C Wasmuth; J K Rockstroh; C Boesecke; C Schwarze-Zander; G Fätkenheuer Journal: Infection Date: 2013-10-01 Impact factor: 3.553